These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

745 related articles for article (PubMed ID: 27570425)

  • 21. Prevention and treatment effect of total flavonoids in Stellera chamaejasme L. on nonalcoholic fatty liver in rats.
    Wang Y; Li JY; Han M; Wang WL; Li YZ
    Lipids Health Dis; 2015 Aug; 14():85. PubMed ID: 26242978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of herbs and active ingredients ameliorate non-alcoholic fatty liver disease under the guidance of traditional Chinese medicine.
    Zhou Z; Zhang J; You L; Wang T; Wang K; Wang L; Kong X; Gao Y; Sun X
    Front Endocrinol (Lausanne); 2022; 13():1000727. PubMed ID: 36204095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Traditional medicine in the treatment of drug addiction.
    Lu L; Liu Y; Zhu W; Shi J; Liu Y; Ling W; Kosten TR
    Am J Drug Alcohol Abuse; 2009; 35(1):1-11. PubMed ID: 19152199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural Aldose Reductase Inhibitor: A Potential Therapeutic Agent for Non-alcoholic Fatty Liver Disease.
    Qiu L; Guo C
    Curr Drug Targets; 2020; 21(6):599-609. PubMed ID: 31589122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Does herbal medicine reduce the risk of hepatocellular carcinoma?
    Rino Y; Yukawa N; Yamamoto N
    World J Gastroenterol; 2015 Oct; 21(37):10598-603. PubMed ID: 26457019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insight of Chinese Herbal Medicine in Treating Osteoporosis: Achievements from 2013 to 2023.
    Tan M; Li Q; Yang B; Wang S; Chen Z
    Am J Chin Med; 2024; 52(5):1303-1328. PubMed ID: 39192680
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In-silico studies in Chinese herbal medicines' research: evaluation of in-silico methodologies and phytochemical data sources, and a review of research to date.
    Barlow DJ; Buriani A; Ehrman T; Bosisio E; Eberini I; Hylands PJ
    J Ethnopharmacol; 2012 Apr; 140(3):526-34. PubMed ID: 22326356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacological Effects of Active Components of Chinese Herbal Medicine in the Treatment of Alzheimer's Disease: A Review.
    Wang ZY; Liu JG; Li H; Yang HM
    Am J Chin Med; 2016; 44(8):1525-1541. PubMed ID: 27848250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent progress on anti-liver fibrosis candidates in patents of herbal medicinal products.
    Wang XB; Feng Y; Wang N; Cheung F; Wong CW
    Recent Pat Food Nutr Agric; 2012 Aug; 4(2):91-106. PubMed ID: 22594662
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the mechanism of PingTang No.5 capsule on nonalcoholic fatty liver disease through network pharmacology and experimental validation.
    Hung TC; Zhao N; Huang C; Liu S; Liu T; Huang W; Xu X; Ji ZL; Yang S
    Biomed Pharmacother; 2021 Jun; 138():111408. PubMed ID: 33684693
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Future development of global regulations of Chinese herbal products.
    Fan TP; Deal G; Koo HL; Rees D; Sun H; Chen S; Dou JH; Makarov VG; Pozharitskaya ON; Shikov AN; Kim YS; Huang YT; Chang YS; Jia W; Dias A; Wong VC; Chan K
    J Ethnopharmacol; 2012 Apr; 140(3):568-86. PubMed ID: 22373513
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A strategy for evaluating antipyretic efficacy of Chinese herbal medicines based on UV spectra fingerprints.
    Ni LJ; Zhang LG; Hou J; Shi WZ; Guo ML
    J Ethnopharmacol; 2009 Jul; 124(1):79-86. PubMed ID: 19527822
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Literature Review on the Use of Herbal Extracts in the Treatment of Non- Alcoholic Fatty Liver Disease.
    Wang Y; Wu J; Shi A
    Endocr Metab Immune Disord Drug Targets; 2022; 22(11):1123-1145. PubMed ID: 35400330
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Natural medicines for alcoholism treatment: a review.
    Xu BJ; Zheng YN; Sung CK
    Drug Alcohol Rev; 2005 Nov; 24(6):525-36. PubMed ID: 16361209
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Schisandra chinensis extract ameliorates nonalcoholic fatty liver via inhibition of endoplasmic reticulum stress.
    Jang MK; Nam JS; Kim JH; Yun YR; Han CW; Kim BJ; Jeong HS; Ha KT; Jung MH
    J Ethnopharmacol; 2016 Jun; 185():96-104. PubMed ID: 26972505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Traditional Chinese medicines benefit to nonalcoholic fatty liver disease: a systematic review and meta-analysis.
    Shi KQ; Fan YC; Liu WY; Li LF; Chen YP; Zheng MH
    Mol Biol Rep; 2012 Oct; 39(10):9715-22. PubMed ID: 22718512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Status of Herbal Medicines in Chronic Liver Disease Therapy: The Biological Effects, Molecular Targets and Future Prospects.
    Hong M; Li S; Tan HY; Wang N; Tsao SW; Feng Y
    Int J Mol Sci; 2015 Dec; 16(12):28705-45. PubMed ID: 26633388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Toxicities by herbal medicines with emphasis to traditional Chinese medicine.
    Efferth T; Kaina B
    Curr Drug Metab; 2011 Dec; 12(10):989-96. PubMed ID: 21892916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanism insights into the pleiotropic effects of nobiletin as a potential therapeutic agent on non-alcoholic fatty liver disease (NAFLD).
    Ran Q; Gan Q; Zhu Y; Song L; Shen L; Duan X; Zhu X; Huang W
    Biomed Pharmacother; 2024 Apr; 173():116322. PubMed ID: 38401524
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The potential of flavonoids in the treatment of non-alcoholic fatty liver disease.
    Van De Wier B; Koek GH; Bast A; Haenen GR
    Crit Rev Food Sci Nutr; 2017 Mar; 57(4):834-855. PubMed ID: 25897647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.